| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.6 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |